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Background: The T594M variant of the b-subunit of the sodium epithelial channel (ENaC)
gene may contribute to hypertension in individuals of Indo-Aryan origin.
Methods: Present study was performed to assess the role of the ENaC gene variant as an
independent risk factor for hypertension in subjects of Indo-Aryan ancestry. A total of 150
patients of recently detected essential hypertension and 150 matched controls were gen-
otyped for the T594M polymorphism of the ENaC gene by PCReRFLP method.
Results: b-T594M mutation was found to be non-polymorphic. There was major genotype
call in both the groups i.e. cases and controls. Other phenotypic parameters like age, sex
and body mass index were also similar among hypertensive patients and controls
(P > 0.05). Hypertensive patients had significantly higher total cholesterol and triglycerides
compared with controls (P < 0.0001).
Conclusion: These results do not suggest an important role for the T594M variant of the
ENaC gene contributing to either the development or severity of hypertension in subjects of
Indo-Aryan ancestry.
Copyright © 2014, Cardiological Society of India. All rights reserved.iology, G.B. Pant Hospital, Room 125, Academic Block, First Floor, New Delhi 110002, India.
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Essential hypertension (EH) is a multifactorial trait with about
30%e60% of the phenotypic variation being attributed to ge-
netic factors.1 Some genetic causes of human hypertension
involve increased renal tubular sodium absorption, either
indirectly through excessmineralocorticoid activity or directly
as in Liddle's syndrome.2 This syndrome is caused by muta-
tions of subunits of the epithelial sodium channel (ENaC) that
result in increased sodium-channel activity in the distal renal
tubule with excess sodium reabsorption leading to high blood
pressure and the characteristic suppression of the
renineangiotensin system. The clinical features of Liddle's
syndrome overlap with those of some patients with EH. Genes
involved in monogenic-mendelian form of hypertension are
much easier to map than those involved in multifactorial
human hypertension. Despite the rarity of this syndrome, the
identification of the corresponding genes may help to clarify
the genetics of EH for two reasons: “milder” variants in these
same genes may be relatively frequent in the general popula-
tion and contribute to common EH; and similar physiologic
pathways may be relevant to both rare and common forms of
hypertension. Gain of functionmutations in the b or g subunit
of the ENaC gene result in an increase in sodium-channel ac-
tivity like Liddle's syndrome,mutationswhich are identified in
patients with EH as well.2e4 Therefore, it is possible that
sodium-channel mutations in patients with EH could
contribute to the rise in blood pressure by increasing renal
tubular sodium reabsorption. The first molecular variant to
showanassociationwithhypertensionwasT594M (rs1799979)
in the C-terminus of b-ENaC. Among the polymorphisms
identified in the b subunit of ENaC, b-T594M and b-G442V are
seen in individuals of African origin.5,6 T594M is amissense, C/
Tmutation leading to substitutionof threonine bymethionine.
The physiological significance of the T594M polymorphisms
could partly explain the high incidence of salt-sensitive hy-
pertension in African Americans.5e7 Based on these in-
formations we hypothesized that b-T594M polymorphism of
epithelial sodium channel gene, which has a role in sodium
balance,maybeassociatedwithEH innorth Indianpatients. To
address this question, we screened b-T594M polymorphism of
epithelial sodium channel gene in a caseecontrol design and
looked for its association with hypertension. This study will
help us in understanding the role of b-T594Mpolymorphismof
epithelial sodiumchannel gene in thepathophysiologyof EH in
North Indian population, and hencewill provide uswith better
leads in extent of involvement of salt sensitivity in this
polulation.2. Materials and methods
2.1. Study subjects and clinical evaluation
Since the present study was a pilot study to investigate the
mentioned polymorphism, age, gender and ethnicitymatched
hypertensive and control subject (case-control design) of
Indo-Aryan ancestry from North India were selected. The
study was approved by human ethical committee; writteninformed consent was obtained from each participant. Pa-
tients and controls were recruited from hypertension and
general outpatient department, GB Pant Hospital, respectively
and some controls were also recruited from blood bank, GB
Pant Hospital. The patient's inclusion criteria included: age
25e60 years, diastolic blood pressure (DBP) 90mmHg and/or
systolic blood pressure (SBP) 140mmHg. The blood pressure
was measured thrice after every 5 min of rest in the seated
position by the same cardiologist. Average of three BP read-
ings was taken. All the patients included were recently diag-
nosed (<1month) with EH. The subject with EHwas diagnosed
as per JNC VII criteria.8 Patients with target organ damage,
secondary form of hypertension, diabetes mellitus, previous
or present history suggestive of coronary artery disease,
women receiving oral contraceptives or hormone replace-
ment therapy, pregnant women or subjects who weighed
greater than 25% of ideal body weight were excluded from the
study. Controls recruitment criteria included: age 25e60 years,
SBP < 120 mm Hg and DBP < 80 mm Hg, absence of family
history of hypertension and any disease medication. Partici-
pants who did not give consent or complied with the study
protocol were excluded from the study. The sample size
comprised of 150 patients and 150 controls.
Family history of hypertension was defined as having fa-
ther, mother, or siblings with a history of EH. The study was
approved by human ethical committee; detailed question-
naire including written informed consent and demographic
characteristics were obtained from each participants.
2.2. Biochemical investigations
Plasma samples were used to determine fasting glucose, lipid
profile, serum uric acid, serum sodium, potassium, serum
creatinine and urinary protein.
2.3. Genetic analysis
Genetic analysis was carried out in CSIR-Institute of Genomics
and Integrative Biology, Delhi. DNA was extracted from 10 ml
peripheral blood taken from each participant. The modified
salting out method was used to extract DNA. Amplification
and genotyping of the candidate gene locus was performed by
Polymerase Chain Reaction (PCR) and Restriction Fragment
Length Polymorphism (RFLP)method. The rigorous process for
initial standardization was done using gradient thermocycler
with different temperature and extension periods. For each
individual SNP, one pair of sense and antisense primer was
designed using DNA STAR software. The concentration of
primers, Mg2þ, genomic DNA, Taq polymerase and di-
nucleotides was also varied according to the need. The
nonspecific amplification was further reduced by hot start,
step down PCRmethods. Each stepwas followed by the proper
amplification check on either agarose gel or on a native Poly-
acrylamide Gel Electrophoresis (PAGE). The exact size was
confirmed on a gene scan using ABI prism 377 Genotyper
sequencer. The PCR product was further digested by NlaIII
(New England Biolabs) for 2 h and the products were analyzed
on a 1.5% agarose gel. The single nucleotide sequence sub-
stitution of T for C in the b-T594M variant creates a unique
NlaIII restriction enzyme site. In case of homozygote wild type
Table 1 e Baseline demographic and clinical
characteristics of the study subjects.
Parameters Controls Patients P-value
n 150 150 e
Female 70 71 0.8
Ethnicity Indo-Aryan Indo-Aryan e
Age, year 49 ± 9.1 50.5 ± 10 0.17
BMI, kg/m2 23 ± 4.5 23.4 ± 4.1 0.42
SBP, mm Hg 116.3 ± 10 166.5 ± 16.4 <0.0001
DBP, mm Hg 77.7 ± 5.8 100.7 ± 8.8 <0.0001
Pulse pressure, mmHg 40 ± 8.4 64 ± 20 <0.0001
MAP, mmHg 91.0 ± 8.7 114.3 ± 16.4 <0.0001
Heart rate, bpm 82 ± 6.6 72 ± 5.5 <0.0001
Total cholesterol, mg/dl 105 ± 23 120 ± 17 <0.0001
Triglyceride, mg/dl 91 ± 26 107 ± 22 <0.0001
Uric acid, mg/dl 4.34 ± 1.3 4.45 ± 1.2 0.44
Glucose, mg/dl 96 ± 15 97 ± 11 0.51
Serum creatinine, mg/dl 1.12 ± 0.38 1.15 ± 0.29 0.44
Serum Naþ, mmol/L 137 ± 2.4 137.7 ± 4.6 0.09
Serum Kþ, mmol/L 4.2 ± 0.46 4.3 ± 0.74 0.16
Proteinurea Nil Nil e
Current smoking None None e
Family history
EH, þ/ (%)
None (þ) 72%, () 28% e
Alcohol, þ/ (%) (þ) 6%, () 94% (þ) 5%, () 95% e
Data are presented as mean ± standard deviation and were
compared by analysis of variance (ANOVA). The comparison be-
tween genders was performed by c2 test. n, number of subjects;
BMI, body mass index; EH, hypertension; SBP, systolic blood pres-
sure (mm Hg); DBP, diastolic blood pressure (mm Hg); MAP, mean
arterial pressure (mm Hg).
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mozygote mutant the 226-bp PCR product can be cleaved into
two fragments, a 117 bp and a 109 bp and in case of hetero-
zygote, both the uncut wild-type 226-bp fragment and the 117/
109-bp variant fragment will be present.
2.4. Statistical analysis
Sample size and power calculations were conducted using
EpiInfo (Version6.0). For sample size calculation, apowerof 80%
to detect an odds ratio of 2 or greaterwith equal number of case
and control with the proportion exposed in the control group
with 20%. Case and controls werematched for age, sex and BMI
by c2-test. Data on continuous variables was presented as
mean ± standard deviation and compared by analysis of vari-
ance (ANOVA). P < 0.05 was considered statistically significant.Table 2 e Genotype distribution of b-T594M
polymorphism in patients and controls.
Genotypes/alleles Patients, n (%) Controls, n (%)
CC 150 (100%) 150 (100%)
CT 0 0
TT 0 0
C 300 (100%) 300 (100%)
T 0 0
n (%), represents no. of subjects (no. of subjects in percentage).3. Observation and results
The study was conducted after screening for subjects, using
the inclusion and exclusion criteria already outlined. Of the
cases, 72% had family history of hypertension while 5%
admitted to taking alcoholmore than 30ml per daymore than
5 days a week. None of the controls had a family history of
hypertension and 6% admitted to taking alcohol.
Thedemographic clinicaland laboratorydataofpatientsand
controls subjects are given in Table 1. Themean age of patients
was 50.5 ± 10 years and controls, 49 ± 9.1 years (P ¼ 0.7).The sex distribution of study subjects is summarized in
Table 1. Among the other parameters, sex, body mass index
and laboratory parameters did not differ between the two
groups (P > 0.05). The table demonstrates a significant
derangement in lipid profiles in the patients compared aswith
controls. Themean total cholesterol of cases and controls was
120 ± 17 and 105 ± 23 mg/dl, while triglycerides were 107 ± 22
and 91 ± 26 mg/dl, respectively. The SBP was significantly
higher in cases (166.5 ± 16.4 mm Hg) as compared with con-
trols (116.3 ± 10 mm Hg); likewise DBP was also significantly
higher among cases (100.7 ± 8.8 mm Hg) than controls
(77.7 ± 5.8 mm Hg) (P < 0.0001).
3.1. Genetic analysis
The genetic data did not show any difference for b-T594M
mutation between patients and controls (Table 2). There was
no change in the amino acid from threonine (T) to methionine
(M). The two groups were homozygous to the wild-type CC
genotype. As a consequence, only C allele was observed in
both the groups.4. Discussion
The critical role of ENaC in sodium reabsorption and the exis-
tence of mutations of b-ENaC at the origin of Liddle's syn-
drome, a rare and severe form of salt-sensitive hypertension,
led to the hypothesis that variants of this channel subunit
could account for a proportion of essential forms of hyper-
tension, especially those characterized with low plasma renin
level.9 There are reports about the b-T594Mmutation showing
significance in thepopulationsofAfricandescent.5e7However,
studies about the role of thismutation in causinghypertension
in Indian population are lacking. Hence this study was taken
up in 150 cases of EH and 150 healthy controls residing pre-
dominantly in central Delhi. Patients with diabetes, over-
weight or obesity were not included as these conditions per se
can lead to hypertension by non-ENaC pathways.
Cases and controls were well matched for age and sex.
They were selected from same region to circumvent popula-
tion stratification.10 Both the groups were equivalent in most
of the biochemical parameters except the total cholesterol
and triglycerides. However, the cases were not dyslipidaemic
as per the ATP criteria.11
With regard to the b-T594Mmutation,we could not observe
any variation in the genotype aswe could obtain only thewild-
type allele homozygotes. Hence, our study did not show any
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population. However, it is important to note that the overall
distribution of this polymorphism even in the population of
African origin was not very high. The distribution, which was
identical in both patients and controls, rangedbetween1.5 and
4.5%, where as one study reported this in 8% of patients
compared with controls (12%).12e15 All these investigations
centered around the same population. It thus becomes inter-
esting that although thepolymorphismappears important due
to amino acid change and also because of the reporting of
causal effect of the mutant allele13; however, the insignificant
distribution in the reported population suggests that the so-
dium channel effect may be the result of additional poly-
morphisms within this gene or other genes, which work in
synergism to bring the pathophysiological effect. One of the
studies has shown that there is increased prevalence of this
mutation inpatients ofAfricandescentbutnot amongwhites.7
Present study has certain limitations. It included only a
particular racial subgroup with small number of patients.
However, this being initial study, we had recruited patients
from Indo-Aryan ancestry only. This limits the wider applica-
bility of the result; however, it doesnot affect the validity. Also,
due to inadequate level of awareness, reliable family history
was not available in a number of cases. Positive family history
would have made us choose those cases that would have a
higher chance of having genetic cause. Further, we did not use
ambulatory blood pressure monitoring though this is unlikely
tohaveanybearing on themain results of our study. Finallywe
have looked into only a single mutation in the ENaC gene.
However, other mutations in the same gene and their haplo-
types may provide more information than single marker.
In Conclusions, the study carried among north Indian
subjects which was initially designed to seek the possible
association between ENaC polymorphism and hypertension,
revealed instead that none of the subjects actually had the
T594M mutation. The study reflects a low frequency of this
polymorphism as has been shown in Caucasian counterparts
in similar studies, warranting further studies.Conflicts of interest
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